THE ALPHA-1C CALCIUM CHANNEL IN MUSCLE
肌肉中的 ALPHA-1C 钙通道
基本信息
- 批准号:6630380
- 负责人:
- 金额:$ 31.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-27 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting RNase protection assay calcium channel dexamethasone electrophysiology electrostimulus gel mobility shift assay gene expression immunocytochemistry laboratory rat microarray technology muscle contraction muscle function myocardium nucleic acid sequence polymerase chain reaction statistics /biometry staurosporine striated muscles tissue /cell culture transcription factor voltage /patch clamp western blottings
项目摘要
DESCRIPTION (Adapted from the applicant's abstract): L-type voltage-gated
calcium channels also known as dihydropyridine receptors (DHPRs) are critical
for excitation-contraction coupling in both skeletal and cardiac muscle. Each
of these muscle types expresses its own isoform of the DHPR. The role of the
alpha1C cardiac DHPR in cardiac muscle is unquestionable to both provide the
influx of Ca2+ needed to trigger Ca2+ release from intracellular stores as well
as to provide a means to refill those stores when they become depleted. In
vascular smooth muscle these same channels are the site of action of nearly all
Ca2+ channel blockers used therapeutically in the treatment of hypertension and
heart disease. Recently certain adult skeletal muscles have been shown to
exhibit not only the alpha1S skeletal isoform of the DHPR, but also the alpha1C
cardiac isoform, although at lower levels of expression. This grant tests
several hypotheses for the role of the cardiac DHPR in adult skeletal muscle.
The hypotheses to be tested include refilling of partially depleted
intracellular Ca2+ stores, forestalling fatigue, and serving to turn off other
genes. Methods will include tension, (Ca2+)i and electrophysiology measurements
and measurements of gene expression. The results may suggest additional roles
for the alpha1C cardiac DHPRs in the heart as well as in many smooth muscles.
This grant also seeks to determine how the steroid hormone dexamethasone, the
protein kinase C inhibitor staurosporine, and electrical stimulation regulate
the expression of the cardiac DHPR in muscle, and to determine the response
elements for the transcription factors involved and for tissue-specific
expression within the gene promoter. Additional methods will include
traditional assays used for promoter work. These results will enhance
understanding of the transcriptional regulation of this extremely important
receptor for therapeutic agents in the treatment of hypertension and heart
disease.
描述(改编自申请人的摘要):L型电压门控
钙通道也称为二氢吡啶受体(DHPR)是关键的
用于骨骼肌和心脏肌肉中的激发反应耦合。每个
这些肌肉类型表达了自己的DHPR同工型。角色
心脏肌肉中的α1c心脏DHPR毫无疑问地提供
还需要触发Ca2+从细胞内存储中释放的Ca2+涌入
为了提供这些商店耗尽时补充这些商店的手段。在
血管平滑肌这些相同的通道几乎是所有的作用部位
CA2+通道阻滞剂用于治疗高血压和
心脏病。最近,某些成年骨骼肌已被证明
不仅展示了DHPR的α1s骨骼同工型,还展示alpha1c
心脏同工型,尽管表达水平较低。此赠款测试
心脏DHPR在成人骨骼肌中的作用的几个假设。
要测试的假设包括部分耗尽的补充
细胞内Ca2+存储,防止疲劳,并关闭其他
基因。方法将包括张力,(CA2+)I和电生理测量值
和基因表达的测量。结果可能表明其他角色
对于心脏以及许多平滑肌肉的α1C心脏DHPR。
该赠款还旨在确定类固醇激素地塞米松如何
蛋白激酶C抑制剂星形孢菌素和电刺激调节
心脏DHPR在肌肉中的表达,并确定反应
涉及的转录因子和组织特异性的元素
基因启动子中的表达。其他方法将包括
用于发起人工作的传统测定法。这些结果将增强
理解这一极为重要的转录调节
治疗高血压和心脏治疗剂的受体
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP T. PALADE其他文献
PHILIP T. PALADE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP T. PALADE', 18)}}的其他基金
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
8389872 - 财政年份:2010
- 资助金额:
$ 31.31万 - 项目类别:
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
8015274 - 财政年份:2010
- 资助金额:
$ 31.31万 - 项目类别:
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
8197452 - 财政年份:2010
- 资助金额:
$ 31.31万 - 项目类别:
MicroRNA to decrease vascular CaV1.2 in hypertension
MicroRNA 可降低高血压患者的血管 CaV1.2
- 批准号:
7785275 - 财政年份:2010
- 资助金额:
$ 31.31万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
6731754 - 财政年份:2003
- 资助金额:
$ 31.31万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
6984144 - 财政年份:2003
- 资助金额:
$ 31.31万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
7215036 - 财政年份:2003
- 资助金额:
$ 31.31万 - 项目类别:
Cav1.2 Transcript Regulation in Heart and Smooth Muscle
Cav1.2 心脏和平滑肌的转录调节
- 批准号:
6837154 - 财政年份:2003
- 资助金额:
$ 31.31万 - 项目类别: